Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations
Por:
Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-Sánchez M, García Sánchez N, Garrote Llanos E, Hernández Merino Á, Iofrío de Arce A, Montesdeoca Melián A, Navarro Gómez ML, Ruiz-Contreras J and en representación del Comité Asesor de Vacunas de la Asociación Española de Ped
Publicada:
1 ene 2021
Ahead of Print:
1 ene 2021
Categoría:
Pediatrics, perinatology and child health
Resumen:
The CAV-AEP annually publishes the immunisation schedule considered optimal for all children and adolescent resident in Spain, taking into account the available evidence.
The 2 + 1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate.A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+ 1 schemes, as welt as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks.
Rotavirus vaccine should be systematic for all infants.
Meningococcal B vaccine, with a 2 + 1 schedule, should be included in routine calendar.
In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups.
Two-dose schedules for triple viral (12 months and 3-4 years) and varicella (15 months and 3.4 years) will be used. The second dose could be applied as a tetraviral vaccine.
Universal systematic vaccination against HPV is recommended, regardless of gender, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders. (C) 2020 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U.
Filiaciones:
Álvarez García FJ:
Centro de Salud de Llanera, Asturias, España
Departamento de Medicina, Universidad de Oviedo, Asturias, España
Cilleruelo Ortega MJ:
Servicio de Pediatría, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, España
Departamento de Pediatría, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España
Álvarez Aldeán J:
Servicio de Pediatría, Hospital Costa del Sol, Málaga, España
:
Centro de Salud Nazaret, Valencia, España
Área de Vacunas, FISABIO, Valencia, España
García Sánchez N:
Centro de Salud Delicias Sur, Zaragoza, España
Departamento de Pediatría, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, España
Garrote Llanos E:
Sección de Infectología, Hospital Universitario Basurto, Bilbao, España
Facultad de Medicina, Universidad del País Vasco, UPV-EHU, Bilbao, España
Hernández Merino Á:
Madrid, España
Iofrío de Arce A:
Centro de Salud El Ranero, Murcia, España
Montesdeoca Melián A:
Centro de Salud de Guanarteme, Las Palmas de Gran Canaria, España
Navarro Gómez ML:
Servicio de Pediatría, Hospital Universitario Gregorio Marañón, Madrid, España
Departamento de Pediatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Ruiz-Contreras J:
Servicio de Pediatría, Hospital Universitario 12 de octubre, Madrid, España
Departamento de Pediatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
gold, Green Published
|